Tsyb A F, Drozdovskiĭ B I, Proshin V V
Vopr Onkol. 1996;42(3):73-5.
The end-results of iodine radionuclide therapy of 62 patients with lung metastases of thyroid cancer have been evaluated. The treatment was carried out in two stages: radical surgery and 131I therapy of metastases. Single dosage was 2,700-5,000 MBq; total dosage-10,000-40,000 MBq. As a result, all patients survived 3 and 5 years.
